Recon: Sanofi to build new €1.3B insulin plant in Frankfurt; Novo launches Wegovy in Australia
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesReconMichael MezherBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States